David J. Grainger

Chief Innovation Officer, Centessa Pharmaceuticals plc.

Companies

Centessa Pharmaceuticals plcChief Innovation Officer Oct 8, 2021 to Jan 2, 2024¹

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Dec 31, 2023Shares withheld for tax 4,700 shares at $7.96 of Centessa Pharmaceuticals plc²
Sep 30, 2023Shares withheld for tax 4,700 shares at $6.47 of Centessa Pharmaceuticals plc³
Jun 30, 2023Shares withheld for tax 4,290 shares at $5.90 of Centessa Pharmaceuticals plc⁴
Mar 31, 2023Shares withheld for tax 4,825 shares at $3.90 of Centessa Pharmaceuticals plc⁵
Feb 1, 2023Granted 77,200 shares of Centessa Pharmaceuticals plc⁶
Dec 31, 2022Shares withheld for tax 2,497 shares at $3.10 of Centessa Pharmaceuticals plc⁷
Oct 3, 2022Sold 2,853 shares at $3.95 of Centessa Pharmaceuticals plc⁸
Sep 30, 2022Sold 2,328 shares at $4.07 of Centessa Pharmaceuticals plc⁸
Sep 30, 2022Shares withheld for tax 7,154 shares at $4.25 of Centessa Pharmaceuticals plc⁹
Jul 1, 2022Granted 100,000 shares of Centessa Pharmaceuticals plc¹⁰
Jan 28, 2022Bought 27,500 shares at $9.05 of Centessa Pharmaceuticals plc¹¹

The numbers on this page point here. Each one links to the record it came from.